PubMed

The paradox of equipoise: the principle that drives and limits therapeutic discoveries in clinical research.

Djulbegovic B.

Cancer Control. 2009 Oct;16(4):342-7.PMID: 19910921 [PubMed - in process]Related articlesFree article

NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma.

Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Gasparetto C, Huff CA, Jagasia M, Medeiros BC, Meredith R, Raje N, Schriber J, Singhal S, Somlo G, Stockerl-Goldstein K, Tricot G, Vose JM, Weber D, Yahalom J, Yunus F.

J Natl Compr Canc Netw. 2009 Oct;7(9):908-42. No abstract available. PMID: 19878637 [PubMed - in process]Related articles

Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis.

Kumar A, List AF, Hozo I, Komrokji R, Djulbegovic B.

Haematologica. 2009 Oct 22. [Epub ahead of print] No abstract available. PMID: 19850902 [PubMed - as supplied by publisher]Related articlesFree article

Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.

Pidala J, Anasetti C, Kharfan-Dabaja MA, Cutler C, Sheldon A, Djulbegovic B.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1415-21. Epub 2009 Sep 1.PMID: 19822301 [PubMed - in process]Related articles

Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer.

Herold CI, Djulbegovic B, Hozo I, Lyman GH.

Breast Cancer Res Treat. 2009 Oct 6. [Epub ahead of print]PMID: 19806449 [PubMed - as supplied by publisher]Related articles

Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis.

Kharfan-Dabaja MA, Mhaskar AR, Djulbegovic B, Cutler C, Mohty M, Kumar A.

Biol Blood Marrow Transplant. 2009 Sep;15(9):1005-13. Epub 2009 Jun 10. Review.PMID: 19660713 [PubMed - indexed for MEDLINE]Related articles

Impact of quality of evidence on the strength of recommendations: an empirical study.

Djulbegovic B, Trikalinos TA, Roback J, Chen R, Guyatt G.

BMC Health Serv Res. 2009 Jul 21;9:120.PMID: 19622148 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review.

Mhaskar R, Kumar A, Behera M, Kharfan-Dabaja MA, Djulbegovic B.

Biol Blood Marrow Transplant. 2009 Aug;15(8):893-902. Epub 2009 Apr 2. Review.PMID: 19589478 [PubMed - indexed for MEDLINE]Related articles

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF, Ray-Coquard I, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007303. Review.PMID: 19588423 [PubMed - indexed for MEDLINE]Related articles

Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).

Briel M, Lane M, Montori VM, Bassler D, Glasziou P, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Culebro CR, da Silva SA, Flynn DN, Elamin MB, Strahm B, Murad MH, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Elnour NO, You JJ, Karanicolas PJ, Bucher HC, Lampropulos JF, Nordmann AJ, Burns KE, Mulla SM, Raatz H, Sood A, Kaur J, Bankhead CR, Mullan RJ, Nerenberg KA, Vandvik PO, Coto-Yglesias F, Schünemann H, Tuche F, Chrispim PP, Cook DJ, Lutz K, Ribic CM, Vale N, Erwin PJ, Perera R, Zhou Q, Heels-Ansdell D, Ramsay T, Walter SD, Guyatt GH.

Trials. 2009 Jul 6;10:49.PMID: 19580665 [PubMed - indexed for MEDLINE]Related articlesFree article

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H, Appelbaum FR, Döhner H, Antin JH, Soiffer RJ, Cutler C.

JAMA. 2009 Jun 10;301(22):2349-61. Review.PMID: 19509382 [PubMed - indexed for MEDLINE]Related articles

Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.

Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL.

Clin Cancer Res. 2009 Jun 1;15(11):3850-5. Epub 2009 May 19.PMID: 19458059 [PubMed - indexed for MEDLINE]Related articles

Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma.

Freedman A, Neelapu SS, Nichols C, Robertson MJ, Djulbegovic B, Winter JN, Bender JF, Gold DP, Ghalie RG, Stewart ME, Esquibel V, Hamlin P.

J Clin Oncol. 2009 Jun 20;27(18):3036-43. Epub 2009 May 4.PMID: 19414675 [PubMed - indexed for MEDLINE]Related articles

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A.

Lancet. 2009 May 2;373(9674):1532-42. Erratum in: Lancet. 2009 Jul 4-2009 Jul 10;374(9683):28. PMID: 19410717 [PubMed - indexed for MEDLINE]Related articles

Epistemologic inquiries in evidence-based medicine.

Djulbegovic B, Guyatt GH, Ashcroft RE.

Cancer Control. 2009 Apr;16(2):158-68.PMID: 19337202 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk prediction versus diagnosis: preserving clinical nuance in a binary world.

Djulbegovic B.

Ann Intern Med. 2009 Feb 3;150(3):223; author reply 224. No abstract available. PMID: 19189922 [PubMed - indexed for MEDLINE]Related articlesFree article

Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.

Kumar A, Kharfan-Dabaja MA, Glasmacher A, Djulbegovic B.

J Natl Cancer Inst. 2009 Jan 21;101(2):100-6. Epub 2009 Jan 13. Review.PMID: 19141779 [PubMed - indexed for MEDLINE]Related articles

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study.

Goy A, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S, Epner E, Krishnan A, Leonard JP, Lonial S, Nasta S, O'Connor OA, Shi H, Boral AL, Fisher RI.

Ann Oncol. 2009 Mar;20(3):520-5. Epub 2008 Dec 12.PMID: 19074748 [PubMed - indexed for MEDLINE]Related articles

Hodgkin disease/lymphoma.

Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2008 Jul;6(6):594-622. No abstract available. PMID: 18597713 [PubMed - indexed for MEDLINE]Related articles

Cancer- and chemotherapy-induced anemia.

Rodgers GM 3rd, Becker PS, Bennett CL, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF, Djulbegovic B, Garst JL, Gilreath JA, Kraut EH, Lin WC, Matulonis U, Millenson M, Reinke D, Rosenthal J, Sabbatini P, Schwartz RN, Stein RS, Vij R; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2008 Jul;6(6):536-64. No abstract available. PMID: 18597709 [PubMed - indexed for MEDLINE]Related articles

Misconceptions, challenges, uncertainty, and progress in guideline recommendations.

Kunz R, Djulbegovic B, Schunemann HJ, Stanulla M, Muti P, Guyatt G.

Semin Hematol. 2008 Jul;45(3):167-75.PMID: 18582623 [PubMed - indexed for MEDLINE]Related articles

Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach.

Hozo I, Schell MJ, Djulbegovic B.

Semin Hematol. 2008 Jul;45(3):150-9.PMID: 18582621 [PubMed - indexed for MEDLINE]Related articles

Multiple myeloma: detecting the effects of new treatments.

Djulbegovic B, Kumar A.

Lancet. 2008 May 17;371(9625):1642-4. No abstract available. PMID: 18486726 [PubMed - indexed for MEDLINE]Related articles

When is diagnostic testing inappropriate or irrational? Acceptable regret approach.

Hozo I, Djulbegovic B.

Med Decis Making. 2008 Jul-Aug;28(4):540-53. Epub 2008 May 13.PMID: 18480041 [PubMed - indexed for MEDLINE]Related articles

Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.

Djulbegovic B, Kumar A, Soares HP, Hozo I, Bepler G, Clarke M, Bennett CL.

Arch Intern Med. 2008 Mar 24;168(6):632-42.PMID: 18362256 [PubMed - indexed for MEDLINE]Related articlesFree article

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.

Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleason KJ, Barnato SE, Elverman KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M.

JAMA. 2008 Feb 27;299(8):914-24. Review.PMID: 18314434 [PubMed - indexed for MEDLINE]Related articlesFree article

Recommendations on the use of 18F-FDG PET in oncology.

Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, Einhorn LH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF.

J Nucl Med. 2008 Mar;49(3):480-508. Epub 2008 Feb 20.PMID: 18287273 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence-Based Medicine: In Its Place.

Djulbegovic B.

Med Decis Making. 2008 Feb 12. [Epub ahead of print] No abstract available. PMID: 18270305 [PubMed - as supplied by publisher]Related articles

Randomized trials in oncology stopped early for benefit.

Wilcox RA, Djulbegovic B, Moffitt HL, Guyatt GH, Montori VM.

J Clin Oncol. 2008 Jan 1;26(1):18-9. Review. No abstract available. PMID: 18165635 [PubMed - indexed for MEDLINE]Related articles

A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.

Tanvetyanon T, Soares HP, Djulbegovic B, Jacobsen PB, Bepler G.

J Thorac Oncol. 2007 Dec;2(12):1091-7. Review.PMID: 18090580 [PubMed - indexed for MEDLINE]Related articles

Estimating net benefits and harms of screening mammography in women age 40 to 49 years.

Djulbegovic B, Hozo I, Lyman GH.

Ann Intern Med. 2007 Dec 18;147(12):882. No abstract available. PMID: 18087062 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.

Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE; American Society of Clinical Oncology; American Society of Hematology.

J Clin Oncol. 2008 Jan 1;26(1):132-49. Epub 2007 Oct 22. Erratum in: J Clin Oncol. 2008 Mar 1;26(7):1192. PMID: 17954713 [PubMed - indexed for MEDLINE]Related articles

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.

Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE.

Blood. 2008 Jan 1;111(1):25-41. Epub 2007 Oct 22. Review. Erratum in: Blood. 2008 Apr 1;111(7):3909. PMID: 17954703 [PubMed - indexed for MEDLINE]Related articlesFree article

Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?

Kharfan-Dabaja MA, Kumar A, Behera M, Djulbegovic B.

Br J Haematol. 2007 Oct;139(2):234-42. Review.PMID: 17897299 [PubMed - indexed for MEDLINE]Related articles

The sound and the fury: financial conflicts of interest in oncology.

Djulbegovic B, Angelotta C, Knox KE, Bennett CL.

J Clin Oncol. 2007 Aug 20;25(24):3567-9. No abstract available. PMID: 17704401 [PubMed - indexed for MEDLINE]Related articles

Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.

Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW.

Arch Intern Med. 2007 May 28;167(10):1041-9.PMID: 17533207 [PubMed - indexed for MEDLINE]Related articlesFree article

Articulating and responding to uncertainties in clinical research.

Djulbegovic B.

J Med Philos. 2007 Mar-Apr;32(2):79-98.PMID: 17454416 [PubMed - indexed for MEDLINE]Related articles

Systematic review of piperacillin-induced neutropenia.

Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, Zagory J, Trifilio S, Jakiche R, Palella F, Kahn A, Chandler K, Bennett CL.

Drug Saf. 2007;30(4):295-306. Review.PMID: 17408306 [PubMed - indexed for MEDLINE]Related articles

Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups.

Kumar A, Soares HP, Balducci L, Djulbegovic B; National Cancer Institute.

J Clin Oncol. 2007 Apr 1;25(10):1272-6. Review.PMID: 17401017 [PubMed - indexed for MEDLINE]Related articles

Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design.

Behera M, Kumar A, Soares HP, Sokol L, Djulbegovic B.

Cancer Control. 2007 Apr;14(2):160-6. Review.PMID: 17387301 [PubMed - indexed for MEDLINE]Related articlesFree article

Multiple myeloma. Clinical practice guidelines in oncology.

Anderson KC, Alsina M, Bensinger W, Biermann JS, Chanan-Khan A, Comenzo RL, De Castro CM, Djulbegovic B, Farag S, Huff CA, Meredith R, Schriber J, Shrieve D, Singhal S, Smith MR, Stockerl-Goldstein K, Vose JM, Weber D, Yahalom J, Yunus F; National Comprehensive Cancer Network (NCCN).

J Natl Compr Canc Netw. 2007 Feb;5(2):118-47. No abstract available. PMID: 17335683 [PubMed - indexed for MEDLINE]Related articles

When should potentially false research findings be considered acceptable?

Djulbegovic B, Hozo I.

PLoS Med. 2007 Feb;4(2):e26.PMID: 17326703 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials.

Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC, Richardson PG, Anderson KC, Soiffer RJ, Alyea EP 3rd.

Biol Blood Marrow Transplant. 2007 Feb;13(2):183-96. Review.PMID: 17241924 [PubMed - indexed for MEDLINE]Related articles

Screening mammography at 40-49 years: regret or no regret?

Djulbegovic B, Lyman GH.

Lancet. 2006 Dec 9;368(9552):2035-7. No abstract available. PMID: 17161713 [PubMed - indexed for MEDLINE]Related articles

Evidence profiles for breast cancer: benefit/harms data based on the totality of randomized evidence.

Soares HP, Kumar A, Djulbegovic B.

Cancer Treat Rev. 2007 Feb;33(1):87-9. Epub 2006 Nov 1. No abstract available. PMID: 17081695 [PubMed]Related articles

Evidence profiles for lung cancer: benefit/harms data based on the totality of randomized evidence.

Soares HP, Kumar A, Djulbegovic B.

Cancer Treat Rev. 2006 Dec;32(8):652-5. Epub 2006 Sep 27. No abstract available. PMID: 17008011 [PubMed]Related articles

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Fisher RI, Bernstein SH, Kahl BS, Djulbegovic B, Robertson MJ, de Vos S, Epner E, Krishnan A, Leonard JP, Lonial S, Stadtmauer EA, O'Connor OA, Shi H, Boral AL, Goy A.

J Clin Oncol. 2006 Oct 20;24(30):4867-74. Epub 2006 Sep 25.PMID: 17001068 [PubMed - indexed for MEDLINE]Related articles

Myeloma (multiple).

Kumar A, Djulbegovic B.

Clin Evid. 2006 Jun;(15):1-29. Review. No abstract available. PMID: 16973003 [PubMed - indexed for MEDLINE]Related articles

Evidence profiles for colo-rectal cancer: benefit/harms data based on the totality of randomized evidence.

Kumar A, Soares HP, Djulbegovic B.

Cancer Treat Rev. 2006 Nov;32(7):577-80. Epub 2006 Aug 21. No abstract available. PMID: 16919883 [PubMed - indexed for MEDLINE]Related articles

What kind of evidence do patients and practitioners need: evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harms.

Djulbegovic B, Soares HP, Kumar A.

Cancer Treat Rev. 2006 Nov;32(7):572-6. Epub 2006 Aug 17. No abstract available. PMID: 16914268 [PubMed - indexed for MEDLINE]Related articles